ACTA1 and chronic myelogenous leukemia, BCR-ABL1 positive: Surprisingly, α-SMA was also expressed by MKs in treated and untreated CML mice, and their numbers were increased in the spleen of CML transgenic mice and elevated in both BM and spleen upon nilotinib treatment.